ClinicalTrials.govpublic full text
VA vs DA for Newly Diagnosed Hig-risk AML
acute myeloid leukemia, adverse risk, newly diagnosed, induction therapy, interventional, phase2, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 881664
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.